29
Participants
Start Date
September 24, 2020
Primary Completion Date
March 28, 2023
Study Completion Date
March 28, 2023
sapablursen
sapablursen administered subcutaneously
Cukurova Üniversitesi Tıp Fakültesi, Adana
Royal Prince Alfred Hospital, Camperdown
Monash Medical Centre, Clayton
Royal Perth Hospital, Perth
Hacettepe Üniversitesi Tıp Fakültesi, Ankara
King Chulalongkorn Memorial Hospital, Pathum Wan
Siriraj Hospital, Bangkok
Thammasat University Hospital, Pathum Thani
İstanbul Üniversitesi - Istanbul Tıp Fakültesi, Topkapı
Ege Universitesi Tip Fakultesi, Izmir
Srinagarind Hospital, Khon Kaen
Maharaj Nakorn Chiang Mai Hospital, Chiang Mai
Naresuan University Hospital, Phitsanulok
Songklanagarind Hospital, Songkhla
Aghia Sophia General Children's Hospital, Athens
University General Hospital of Patras, Patra
Koutlimbaneio & Triantafylleio General Hospital of Larissa, Larissa
Chronic Care Center, Hazmiyeh
Akdeniz University Faculty of Medicine, Antalya
Lead Sponsor
Ionis Pharmaceuticals, Inc.
INDUSTRY